We scout and bolster the Bio&Med Tech champions of tomorrow

Since 2014, we invest in high impact Bio&Med tech early stage startups across Europe and the USA.

We support our portfolio companies in Science, Technology and Execution to empower them into global champions. This our 360° vision.

We have also partnered with centers of excellencies in research, academia or hospitals to source, invest and transform deep science or technology into success stories.

Forepont Capital Partners accelerates medical innovations
through philanthropy and meaningful collaboration.

Forepont Capital Partners gives 10% of our Net Revenues and 10% of our time to the Neurogen Research Foundation

Learn More the 10:10 Program